Effect of 20 mg/day atorvastatin: Recurrent stroke survey in Chinese ischemic stroke patients with prior intracranial hemorrhage

Journal of Clinical Neurology (Korea)

Volumn 9, Issue 3, 2013, Pages 139-143

  Jia, Weihua ^a   Zhou, Lichun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Atorvastatin; Intracranial hemorrhage history; Ischemic stroke; Stroke recurrence

Indexed keywords

EID: 84880048667     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2013.9.3.139     Document Type: Article

References (21)

1. Amarenco P, Bogousslavsky J, Callahan A, Goldstein LB, He-nnerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-559.
2. Morgenstern LB, Hemphill JC, Anderson C, Becker K, Broderick JP, Connolly ES, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010;41:2108-2129.
3. Nakamura H, Arakawa K, Itakura H, Kitabatake A, Goto Y, Toyota T, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet 2006;368:1155-1163.
4. Biff A, Greenberg SM. Cerebral amyloid angiopathy: a systematic review. J Clin Neurol 2011;7:1-9.
5. Thoonsen H, Richard E, Bentham P, Gray R, van Geloven N, De Haan RJ, et al. Aspirin in Alzheimer's disease: increased risk of intracere-bral hemorrhage: cause for concern? Stroke 2010;41:2690-2692.
6. Coutts SB, Hill MD, Simon JE, Sohn CH, Scott JN, Demchuk AM; VISION Study Group. Silent ischemia in minor stroke and TIA patients identified on MR imaging. Neurology 2005;65:513-517.
7. Kimberly WT, Gilson A, Rost NS, Rosand J, Viswanathan A, Smith EE, et al. Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy. Neurology 2009;72:1230-1235.
8. Jia W, Zhou L. Use of antiplatelets. A survey of secondary prevention of ischemic stroke with intracranial hemorrhage history in Chinese patients. Neurosciences (Riyadh) 2011;16:335-339.
9. Weimar C, Benemann J, Terborg C, Walter U, Weber R, Diener HC; German Stroke Study Collaboration. Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study. Cerebro-vasc Dis 2011;32:283-288.
10. Moonis M, Kane K, Schwiderski U, Sandage BW, Fisher M. HMG-CoA reductase inhibitors improve acute ischemic stroke outcome. Stroke 2005;36:1298-1300.
11. Elkind MS, Flint AC, Sciacca RR, Sacco RL. Lipid-lowering agent use at ischemic stroke onset is associated with decreased mortality. Neurology 2005;65:253-258.
12. Bushnell CD, Griffn J, Newby LK, Goldstein LB, Mahaffey KW, Graffagnino CA, et al. Statin use and sex-specific stroke outcomes in patients with vascular disease. Stroke 2006;37:1427-1431.
13. Reeves MJ, Gargano JW, Luo Z, Mullard AJ, Jacobs BS, Majid A; Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators. Effect of pretreatment with statins on ischemic stroke outcomes. Stroke 2008;39:1779-1785.
14. Rocco A, Sykora M, Ringleb P, Diedler J. Impact of statin use and lipid profile on symptomatic intracerebral haemorrhage, outcome and mortality after intravenous thrombolysis in acute stroke. Cerebrovasc Dis 2012;33:362-368.
15. Goldstein LB, Amarenco P, Szarek M, Callahan A, Hennerici M, Sillesen H, et al. Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study. Neurology 2008;70 (24 PT. 2):2364-2370.
16. FitzMaurice E, Wendell L, Snider R, Schwab K, Chanderraj R, Kin-necom C, et al. Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke 2008;39:2151-2154.
17. Kawashima S, Yamashita T, Miwa Y, Ozaki M, Namiki M, Hirase T, et al. HMG-CoA reductase inhibitor has protective effects against stroke events in stroke-prone spontaneously hypertensive rats. Stroke 2003; 34:157-163.
18. Ortego M, Bustos C, Hernández-Presa MA, Tuñón J, Díaz C, Hernán-dez G, et al. Atorvastatin reduces NF-kappaB activation and chemo-kine expression in vascular smooth muscle cells and mononuclear cells. Atherosclerosis 1999;147:253-261.
19. Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, et al. Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci U S A 1998;95:8880-8885.
20. Kureishi Y, Luo Z, Shiojima I, Bialik A, Fulton D, Lefer DJ, et al. The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med 2000;6:1004-1010.
21. Ovbiagele B, Saver JL, Starkman S, Kim D, Ali LK, Jahan R, et al. Statin enhancement of collateralization in acute stroke. Neurology 2007;68:2129-2131.